Important note: Information in this article was accurate in May 2006. The state of the art may have changed since the publication date.
Fatal seronegative visceral leishmaniasis in Portuguese patient
HIV Treat Bull - Vol. 7, No. 5, May 2006
Andrew Benzie and colleagues from St Mary’s reported the case of a 38 year old, ARV-naïve Portuguese man, who presented in April 2005, with a 6-month history of intermittent episodes of high fever, dry cough and shortness of breath on exertion, which increased in severity with each episode.
CD4 count and viral load were 210 cells/mm3 and 34,000 copies/mL respectively, but CD4% was very low at only 6%.
The abstract details that on ‘admission, he was pyrexial with heptosplenomegaly. He was thrombocytopenic (58 · 109/mL) and had a mild neutrophilia. CRP was 127 mg/L and albumin was low at 25 g/L. Chest X-ray and bronchoscopy were normal. Stains and cultures for Pneumocystis, Cryptococcus and Mycobacterium tuberculosis were negative. Initially, he was treated presumptively for community-acquired pneumonia and PCP. Fever resolved and he was commenced on HAART. His condition again deteriorated with worsening thrombocytopenia, hypoalbuminaemia and oedema and respiratory distress. Plasma tested positive for both EBV and HHV8 DNA by PCR. Castleman’s disease was suspected.
Despite negative investigations including serology, bone marrow aspiration with culture for Leishmania, the patient died and post-mortem revealed extensive pulmonary leishmaniasis.
The researchers concluded that diagnosis of visceral leishmaniasis in HIV infection is difficult as only 40-50% of cases have positive Leishmania serology. Clinicians should have a high index of clinical suspicion for visceral leishmaniasis in patients who present with fever and hepatosplenomegaly, despite negative serology and bone marrow aspiration/culture.
COMMENT
Although leishmania and HIV co-infection, is rare in the UK, it is increasingly frequent elsewhere, and could arguably be considered an AIDS defining illness, as immune suppression can activate previously latent infection, and HAART reduces risk of relapse after leishmaniasis treatment.
The most accurate diagnosis in HIV-positive patients is obtained by using PCR.
The highest incidence of leishmaniasis, including cases of coinfection, are probably in Central and South America (especially Brazil); North and East Africa; Asia (India, Bangladesh, Nepal) and in Southern Europe (2000 cases of coinfection were reported by 2003 from Spain, Portugal, France, Italy). In Spain 60% cases of leishmaniasis are in HIV-positive individuals, and leishmaniasis is a notifiable disease.
This report is important for doctors treating patients who come from regions where leishmaniasis is endemic.
Ref: Benzie AA, Goldin RD, Walsh J. A case report of seronegative pulmonary leishmaniasis in an HIV-hepatitis C co-infected patient. Abstract P100.
Links:
Visceral leishmaniasis in those infected with HIV.
https://www.who.int/leishmaniasis/burden/hiv_coinfection/en/ATMP9.pdf [124 Kb]
2008-03-10
IB060705-08
©2008. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.